SJ

Sheela Jyothi

Active Director Director DIN 02963226
DIN 02963226 First appointment Feb 2010 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2010
Shareholding value •••• Premium profile

About Sheela Jyothi

Data last updated:

Sheela Jyothi is a Director at Aap Pharma Technologies India Private Limited (since 2010). The company operates in Pharma. Aap Pharma Technologies India Private Limited reported revenue of ₹41.83 Cr (FY 2024).

DIN 02963226
Primary Designation Director
Industry Pharma
First Appointment 25 Feb 2010
Oldest Company Age 17 yrs
Largest company Aap Pharma Technologies India Private Limited · ₹41.83 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Feb 20102008₹41.83 Cr (FY 2024)Active

Board colleagues of Sheela Jyothi

Directorship timeline

Open interactive timeline →
Aap Pharma Technologies India Private Limited
Premium access

Shareholding and investment profile for Sheela Jyothi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sheela Jyothi

Sheela Jyothi currently holds 1 directorship: Aap Pharma Technologies India Private Limited (Director, since 25 Feb 2010, revenue ₹41.83 Cr (FY 2024)).

Sheela Jyothi was first appointed on 25 Feb 2010 as Director at Aap Pharma Technologies India Private Limited.

The current boards of Sheela Jyothi's companies include Sreenivasulu Guntha (Aap Pharma Technologies India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available